US20040224409A1
(en)
*
|
1992-09-25 |
2004-11-11 |
Laurent Pradier |
Recombinant adenoviruses coding for brain-derived neurotrophic factor (BDNF)
|
US5846782A
(en)
*
|
1995-11-28 |
1998-12-08 |
Genvec, Inc. |
Targeting adenovirus with use of constrained peptide motifs
|
US6465253B1
(en)
|
1994-09-08 |
2002-10-15 |
Genvec, Inc. |
Vectors and methods for gene transfer to cells
|
US6127525A
(en)
*
|
1995-02-21 |
2000-10-03 |
Cornell Research Foundation, Inc. |
Chimeric adenoviral coat protein and methods of using same
|
US5770442A
(en)
*
|
1995-02-21 |
1998-06-23 |
Cornell Research Foundation, Inc. |
Chimeric adenoviral fiber protein and methods of using same
|
US5952226A
(en)
*
|
1996-11-05 |
1999-09-14 |
Modex Therapeutiques |
Hypoxia responsive EPO producing cells
|
US5833651A
(en)
*
|
1996-11-08 |
1998-11-10 |
Medtronic, Inc. |
Therapeutic intraluminal stents
|
US6696423B1
(en)
|
1997-08-29 |
2004-02-24 |
Biogen, Inc. |
Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta
|
US6537806B1
(en)
|
1998-06-02 |
2003-03-25 |
University Of Washington |
Compositions and methods for treating diabetes
|
WO1999062562A1
(en)
*
|
1998-06-02 |
1999-12-09 |
University Of Washington |
Prosthetic implant and methods of use for therapeutic gene expression
|
US20030017138A1
(en)
|
1998-07-08 |
2003-01-23 |
Menzo Havenga |
Chimeric adenoviruses
|
US6929946B1
(en)
|
1998-11-20 |
2005-08-16 |
Crucell Holland B.V. |
Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
|
US6913922B1
(en)
|
1999-05-18 |
2005-07-05 |
Crucell Holland B.V. |
Serotype of adenovirus and uses thereof
|
US6492169B1
(en)
|
1999-05-18 |
2002-12-10 |
Crucell Holland, B.V. |
Complementing cell lines
|
US7235233B2
(en)
|
2000-09-26 |
2007-06-26 |
Crucell Holland B.V. |
Serotype 5 adenoviral vectors with chimeric fibers for gene delivery in skeletal muscle cells or myoblasts
|
AU2003203527A1
(en)
*
|
2002-04-12 |
2003-10-30 |
Sumitomo Electric Industries, Ltd. |
Control of the ratio of lap to lip
|
NZ534866A
(en)
|
2002-04-25 |
2007-04-27 |
Crucell Holland B |
Means and methods for the production of adenovirus vectors
|
AU2003240640B2
(en)
|
2002-05-15 |
2009-10-22 |
Integragen |
Human obesity susceptibility gene and uses thereof
|
DK1656458T3
(da)
|
2003-08-22 |
2009-08-24 |
Integragen Sa |
Human autisme-susceptibilitetsgen og anvendelser deraf
|
CA2571370A1
(en)
|
2004-07-01 |
2006-01-12 |
Integragen |
Human autism susceptibility gene encoding prkcb1 and uses thereof
|
DE602006017045D1
(de)
|
2005-03-24 |
2010-11-04 |
Integragen Sa |
Ein transmembranprotein kodierendes humanes autismus-suszeptibilitätsgen und dessen verwendung
|
EP1835036A1
(de)
|
2006-03-16 |
2007-09-19 |
Exonhit Therapeutics SA |
Zusammensetzungen und Methoden zur Nachweis und Behandlung von Krebs
|
EP2172226A4
(de)
|
2007-06-29 |
2010-06-30 |
Stelic Institute Regenerative Medicine |
Verfahren zur fixierung und zur expression einer physiologisch aktiven substanz
|
EP2027868A1
(de)
|
2007-08-24 |
2009-02-25 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Verwendung von SCO-Spondin zur Hemmung oder Verhinderung von durch Zelltod-Rezeptor-Liganden vermittelter Apoptose
|
PT2238170T
(pt)
|
2008-01-31 |
2017-02-21 |
Inserm - Inst Nat De La Santé Et De La Rech Médicale |
Anticorpos contra cd39 humano e seu uso para inibição da actividade de células t reguladoras
|
US8481033B2
(en)
|
2008-10-07 |
2013-07-09 |
INSERM (Institute National de la Santé et de la Recherche Médicale) |
Neutralizing antibodies and fragments thereof directed against platelet factor-4 variant 1 (PF4V1)
|
EP2199387A1
(de)
|
2008-12-19 |
2010-06-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Serinproteasederivate und deren Verwendung zur Vorbeugung und/oder Behandlung von Blutgerinnungsstörungen
|
ES2629099T3
(es)
|
2008-12-19 |
2017-08-07 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Derivados de serin proteasa y usos en la prevención o el tratamiento de y trastornos de la coagulación sanguinea
|
WO2010106051A1
(en)
|
2009-03-17 |
2010-09-23 |
Universite De La Mediterranee |
Btla antibodies and uses thereof
|
EP2427205A2
(de)
|
2009-05-04 |
2012-03-14 |
INSERM - Institut National de la Santé et de la Recherche Médicale |
Par2-agonisten zur verwendung bei der behandlung oder prävention von infektionen mit dem grippevirus typ a
|
ES2615881T3
(es)
|
2009-05-07 |
2017-06-08 |
Stallergenes |
Uso de inmunoglobulinas igg1 y/o de ligandos del receptor cd32 para el tratamiento de enfermedades y manifestaciones inflamatorias por vía mucosa.
|
US9050276B2
(en)
|
2009-06-16 |
2015-06-09 |
The Trustees Of Columbia University In The City Of New York |
Autism-associated biomarkers and uses thereof
|
WO2011048443A1
(en)
|
2009-10-20 |
2011-04-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Neuronal exocytosis inhibiting peptides derived from c subunit of v-atpase and cosmetic and pharmaceutical compositions containing said peptides
|
WO2011080322A1
(en)
|
2009-12-30 |
2011-07-07 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Method of prognosing the outcome of acquired hemophilia and of treatment of hemophilia
|
WO2011086137A1
(en)
|
2010-01-13 |
2011-07-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Promyelocytic leukemia protein as a redox sensor
|
EP3741383A1
(de)
|
2010-04-08 |
2020-11-25 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Aus trem-ähnlichen transkript 1 (tlt-1) abgeleitete hemmungspeptide und verwendungen davon
|
EP2575853B1
(de)
|
2010-05-25 |
2016-08-24 |
INSERM - Institut National de la Santé et de la Recherche Médicale |
Verfahren und pharmazeutische zusammensetzung zur behandlung einer frühzeitigen nahrungsaufnahmestörung bei einem patienten
|
WO2012004416A2
(en)
|
2010-07-09 |
2012-01-12 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Treatment of a disease associated with retinal degenerative disorder
|
US9040671B2
(en)
|
2010-07-23 |
2015-05-26 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Methods for cancer management targeting Co-029
|
JP5937088B2
(ja)
|
2010-10-15 |
2016-06-22 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
ハンチントン病の治療法におけるコレステロール−24−ヒドロラーゼのための発現ベクター
|
WO2012080769A1
(en)
|
2010-12-15 |
2012-06-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti-cd277 antibodies and uses thereof
|
ES2684602T3
(es)
|
2010-12-22 |
2018-10-03 |
Orega Biotech |
Anticuerpos contra CD39 humano y uso de los mismos
|
EP2658869B1
(de)
|
2010-12-30 |
2019-06-12 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antigenbindende formate zur verwendung in therapeutischen behandlungen oder diagnosetests
|
WO2012101125A1
(en)
|
2011-01-24 |
2012-08-02 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Specific antibodies against human cxcl4 and uses thereof
|
WO2012120131A1
(en)
|
2011-03-09 |
2012-09-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for generating cell microparticles
|
WO2012120129A1
(en)
|
2011-03-10 |
2012-09-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical composition for the treatment of infectious diseases
|
JP6220774B2
(ja)
|
2011-03-31 |
2017-10-25 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
Icosに対する抗体及びその使用
|
WO2012156309A1
(en)
|
2011-05-13 |
2012-11-22 |
Millegen |
Antibodies against her3
|
WO2012156532A1
(en)
|
2011-05-19 |
2012-11-22 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti-human-her3 antibodies and uses thereof
|
US9051562B2
(en)
|
2011-06-15 |
2015-06-09 |
Institut National De La Santé Et De La Recherche Médicale (Inserm) |
Polypeptides isolated from brevibacterium aurantiacum and their use for the treatment of cancer
|
ES2677367T3
(es)
|
2011-06-22 |
2018-08-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anticuerpos anti-Axl y usos de los mismos
|
KR20140104944A
(ko)
|
2011-06-22 |
2014-08-29 |
인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) |
항-axl 항체 및 그의 용도
|
EP2543677A1
(de)
|
2011-07-08 |
2013-01-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antikörper zur Behandlung und Vorbeugung von Thrombose
|
EP2543679A1
(de)
|
2011-07-08 |
2013-01-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antikörper zur Behandlung und Vorbeugung von Thrombose
|
EP2543678A1
(de)
|
2011-07-08 |
2013-01-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antikörper zur Behandlung und Vorbeugung von Thrombose
|
FR2979346B1
(fr)
|
2011-08-23 |
2013-09-27 |
Univ Joseph Fourier |
Nanocorps anti-vcam-1
|
US20140235492A1
(en)
|
2011-09-20 |
2014-08-21 |
Institut National De La Sante Et De La Recherche Medicate (Inserm) |
Methods for preparing single domain antibody microarrays
|
US10039777B2
(en)
|
2012-03-20 |
2018-08-07 |
Neuro-Lm Sas |
Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders
|
WO2013174835A1
(en)
|
2012-05-22 |
2013-11-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for screening a candidate compound for its pharmacology on a nuclear receptor
|
WO2013174998A1
(en)
|
2012-05-25 |
2013-11-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for selecting binders by phage display and masked selection
|
US9676847B2
(en)
|
2012-06-25 |
2017-06-13 |
Orega Biotech |
IL-17 antagonist antibodies
|
EP2692732A1
(de)
|
2012-08-03 |
2014-02-05 |
Stallergenes S.A. |
Neues Allergen aus Kreuzkrautpollen und Verwendung davon
|
WO2014033327A1
(en)
|
2012-09-03 |
2014-03-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies directed against icos for treating graft-versus-host disease
|
CN104837865B
(zh)
|
2012-09-07 |
2019-09-24 |
国立健康与医学研究所 |
衍生自髓样细胞触发受体-1(trem-1)trem-样转录物1(tlt-1)的抑制肽及其用途
|
WO2014057134A1
(en)
|
2012-10-12 |
2014-04-17 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Csn5 polypeptides and uses thereof for screening therapeutic agents
|
EP2733153A1
(de)
|
2012-11-15 |
2014-05-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Verfahren zur Herstellung von Immunkonjugaten und Verwendungen davon
|
KR102408660B1
(ko)
|
2012-11-20 |
2022-06-15 |
사노피 |
항-ceacam5 항체 및 이의 용도
|
US11013783B2
(en)
|
2012-12-26 |
2021-05-25 |
Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement |
Anti-inflammatory peptides and methods for treating inflammatory diseases
|
EP2749289A1
(de)
|
2012-12-26 |
2014-07-02 |
Institut National De La Recherche Agronomique (INRA) |
Entzündungshemmende Peptide
|
WO2014102299A2
(en)
|
2012-12-27 |
2014-07-03 |
Sanofi |
Anti-lamp1 antibodies and antibody drug conjugates, and uses thereof
|
US9066966B2
(en)
|
2013-02-01 |
2015-06-30 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Methods and pharmaceutical compositions for the treatment of cardiomyopathy due to friedreich ataxia
|
ES2698375T3
(es)
|
2013-06-27 |
2019-02-04 |
Inst Nat Sante Rech Med |
Antagonistas de interleucina 15 (IL-15) y usos de los mismos para el tratamiento de enfermedades autoinmunes y enfermedades inflamatorias
|
EP2824176A1
(de)
|
2013-07-11 |
2015-01-14 |
Siamed'xpress |
Verfahren zur Herstellung von sialylierten therapeutischen Proteinen
|
JP2016537995A
(ja)
|
2013-11-05 |
2016-12-08 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
新しいアルツハイマー病動物モデル
|
US10196455B2
(en)
|
2013-11-07 |
2019-02-05 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Neuregulin allosteric anti-HER3 antibody
|
KR20160108540A
(ko)
|
2014-01-20 |
2016-09-19 |
사노피 |
증가된 효소 활성을 갖는 신규한 시토크롬 p450 폴리펩티드
|
FR3020063A1
(fr)
|
2014-04-16 |
2015-10-23 |
Gamamabs Pharma |
Anticorps humain anti-her4
|
US10544231B2
(en)
|
2014-04-16 |
2020-01-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies for the prevention or the treatment of bleeding episodes
|
ES2796857T3
(es)
|
2014-04-17 |
2020-11-30 |
Inst Nat Sante Rech Med |
Polipéptidos y usos de los mismos para reducir la motilidad celular mediada por CD95
|
FR3021970B1
(fr)
|
2014-06-06 |
2018-01-26 |
Universite Sciences Technologies Lille |
Anticorps dirige contre la galectine 9 et inhibiteur de l'activite suppressive des lymphocytes t regulateurs
|
EP2974735A1
(de)
|
2014-07-15 |
2016-01-20 |
Institut National De La Recherche Agronomique (INRA) |
Entzündungshemmende Eigenschaften eines Oberflächenproteins aus Propionibakterium freudenreichii
|
US10398774B2
(en)
|
2014-12-09 |
2019-09-03 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Human monoclonal antibodies against AXL
|
TW202130662A
(zh)
|
2015-01-23 |
2021-08-16 |
法商賽諾菲公司 |
特異性結合cd3及/或cd123之抗—cd3抗體,抗—cd123抗體及雙特異性抗體
|
WO2016135041A1
(en)
|
2015-02-26 |
2016-09-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Fusion proteins and antibodies comprising thereof for promoting apoptosis
|
US11040113B2
(en)
|
2015-03-23 |
2021-06-22 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical composition for the treatment and the prevention of neurological phenotype associated with Friedreich ataxia
|
EP3091033A1
(de)
|
2015-05-06 |
2016-11-09 |
Gamamabs Pharma |
Anti-human-her3-antikörper und verwendungen davon
|
WO2016184967A1
(en)
|
2015-05-20 |
2016-11-24 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Treatment of retinal detachment
|
JP6770533B2
(ja)
|
2015-05-22 |
2020-10-14 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
Cath−Dの触媒活性と、そのLRP1レセプターへの結合との両方を阻害するヒトモノクローナル抗体フラグメント
|
US20180201687A1
(en)
|
2015-07-07 |
2018-07-19 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies having specificity to myosin 18a and uses thereof
|
WO2017029391A1
(en)
|
2015-08-20 |
2017-02-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New method for treating cancer
|
JP6800219B2
(ja)
|
2015-09-16 |
2020-12-16 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
特異的なインターロイキン−15(il−15)アンタゴニストポリペプチド並びに炎症疾患及び自己免疫疾患の処置のためのその使用
|
ES2940360T3
(es)
|
2015-09-22 |
2023-05-05 |
Inst Nat Sante Rech Med |
Polipéptidos capaces de inhibir la unión entre leptina y neuropilina-1
|
WO2017050955A1
(en)
|
2015-09-24 |
2017-03-30 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Agents capable of inhibiting the binding between leptin and vegf165
|
EP4119168A1
(de)
|
2016-01-19 |
2023-01-18 |
The Regents of the University of California |
Verfahren zur behandlung von morbus danon und anderen autophagieerkrankungen
|
EP3419999B1
(de)
|
2016-02-26 |
2021-08-04 |
(INSERM) Institut National de la Santé et de la Recherche Médicale |
Antikörper mit spezifizität für btla und verwendungen davon
|
CN114907483A
(zh)
|
2016-03-22 |
2022-08-16 |
国家医疗保健研究所 |
人源化抗claudin-1抗体及其用途
|
TWI790206B
(zh)
|
2016-07-18 |
2023-01-21 |
法商賽諾菲公司 |
特異性結合至cd3和cd123的雙特異性抗體樣結合蛋白
|
KR102487356B1
(ko)
|
2016-07-29 |
2023-01-12 |
엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔 |
종양 관련 대식세포를 표적화하는 항체 및 이의 용도
|
US20200165302A1
(en)
|
2016-09-14 |
2020-05-28 |
Université Catholique de Louvain |
Modified vsv-g and vaccines thereof
|
TW202300515A
(zh)
|
2016-10-20 |
2023-01-01 |
法商賽諾菲公司 |
抗chikv抗體及其用途
|
CN110121508A
(zh)
|
2016-10-25 |
2019-08-13 |
法国国家健康和医学研究院 |
与cd160跨膜同种型结合的单克隆抗体
|
FR3058143B1
(fr)
|
2016-10-27 |
2021-03-12 |
Univ Grenoble Alpes |
Nanocorps anti-tau
|
MX2019005235A
(es)
|
2016-11-09 |
2019-12-05 |
Intrexon Corp |
Constructos de expresion de frataxina.
|
HUE061905T2
(hu)
|
2017-01-30 |
2023-08-28 |
Brainvectis |
Expresszós vektor koleszterin-24-hidrolázhoz, poliglutamin-ismétlõdéses spinocerebelláris ataxiák kezelésében
|
JP2020510432A
(ja)
|
2017-03-02 |
2020-04-09 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
Nectin−4への特異性を有する抗体及びその使用
|
KR102584011B1
(ko)
|
2017-03-16 |
2023-09-27 |
이나뜨 파르마 에스.에이. |
암 치료를 위한 조성물 및 방법
|
WO2018178051A1
(en)
|
2017-03-28 |
2018-10-04 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Scgb1a1 polymorphism for the prediction and therapy or prevention of primary graft dysfunction
|
EP3388072A1
(de)
|
2017-04-10 |
2018-10-17 |
Universität Leipzig |
Ubichinonunabhängige cytoplasmische dihydroorotat-dehydrogenase zur verwendung als arzneimittel
|
CN110914414A
(zh)
|
2017-06-14 |
2020-03-24 |
德累斯顿工业大学 |
利用设计dna重组酶遗传改变基因组的方法与手段
|
US11174322B2
(en)
|
2017-07-24 |
2021-11-16 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies and peptides to treat HCMV related diseases
|
WO2019038420A1
(en)
|
2017-08-25 |
2019-02-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF OSTEOCLAST DISEASES
|
MX2020003219A
(es)
|
2017-09-21 |
2020-07-20 |
Imcheck Therapeutics Sas |
Anticuerpos que tienen especificidad para btn2 y usos de los mismos.
|
EP3807316B1
(de)
|
2018-06-18 |
2024-05-01 |
Innate Pharma |
Zusammensetzungen und verfahren zur behandlung von krebs
|
US20220054597A1
(en)
|
2018-10-29 |
2022-02-24 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Expression vector for cholesterol 24-hydrolase in therapy of amyotrophic lateral sclerosis
|
WO2020148207A1
(en)
|
2019-01-14 |
2020-07-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Human monoclonal antibodies binding to hla-a2
|
EP3911670A1
(de)
|
2019-01-15 |
2021-11-24 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Mutierte interleukin-34 (il-34)-polypeptide und verwendungen davon in der therapie
|
MX2021011334A
(es)
|
2019-03-20 |
2021-12-10 |
Imcheck Therapeutics Sas |
Anticuerpos que tienen especificidad para btn2 y usos de los mismos.
|
EP3942026A1
(de)
|
2019-03-22 |
2022-01-26 |
Université de Paris |
Neue inhibitoren der lrrk2/pp1-interaktion
|
EP3947446A1
(de)
|
2019-03-25 |
2022-02-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Behandlung von tauopathie-erkrankungen durch abzielen auf neue tau-spezies
|
US20220251232A1
(en)
|
2019-05-20 |
2022-08-11 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Novel anti-cd25 antibodies
|
US20220233654A1
(en)
|
2019-05-21 |
2022-07-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Expression vector for cholesterol 24-hydrolase in therapy of rett syndrome
|
WO2020254619A1
(en)
|
2019-06-20 |
2020-12-24 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti- protease nexin-1 conformational single domain antibodies and uses thereof
|
US20220251567A1
(en)
|
2019-07-10 |
2022-08-11 |
Inserm (Institut National De La Santè Et De La Recherche Médicale) |
Methods for the treatment of epilepsy
|
JP2022541200A
(ja)
|
2019-07-16 |
2022-09-22 |
インサーム(インスティテュ ナシオナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシェ メディカル) |
Cd38に特異性を有する抗体及びその使用
|
WO2021009299A1
(en)
|
2019-07-17 |
2021-01-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Bcl-xl:fkbp12 fusion proteins suitable for screening agents capable of slowing down the aging process
|
DE102019121007A1
(de)
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Antigenbindende Proteine, die spezifisch an MAGE-A binden
|
US20210032370A1
(en)
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Recruiting agent further binding an mhc molecule
|
WO2021023624A1
(en)
|
2019-08-02 |
2021-02-11 |
Orega Biotech |
Novel il-17b antibodies
|
US20220265659A1
(en)
|
2019-09-02 |
2022-08-25 |
Inserm (Institut National De La Santé Et De Al Recherche Médicale) |
Methods and compositions for treating pax6-deficiency related disease
|
WO2021043933A1
(en)
|
2019-09-04 |
2021-03-11 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies specific for il20-rb and uses thereof for the treatment of acute exacerbation of chronic obstructive pulmonary disease
|
WO2021048171A1
(en)
|
2019-09-10 |
2021-03-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method to improve phagocytosis
|
US20220331417A1
(en)
|
2019-09-24 |
2022-10-20 |
Université Catholique de Louvain |
Modified vesicular stomatitis virus glycoprotein and uses thereof for the treatment of brain tumors
|
WO2021058729A1
(en)
|
2019-09-27 |
2021-04-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti-müllerian inhibiting substance type i receptor antibodies and uses thereof
|
WO2021058763A1
(en)
|
2019-09-27 |
2021-04-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti-müllerian inhibiting substance antibodies and uses thereof
|
EP3812008A1
(de)
|
2019-10-23 |
2021-04-28 |
Gamamabs Pharma |
Amh-kompetitiver antagonistischer antikörper
|
EP4061943A1
(de)
|
2019-11-19 |
2022-09-28 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Antisense-oligonukleotide und deren verwendung zur behandlung von krebs
|
JP2023502712A
(ja)
|
2019-11-21 |
2023-01-25 |
インサーム(インスティテュ ナシオナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシェ メディカル) |
抗pd-1/il-15免疫サイトカインによる新しいpd-1標的免疫療法
|
US20230040928A1
(en)
|
2019-12-09 |
2023-02-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies having specificity to her4 and uses thereof
|
WO2021144020A1
(en)
|
2020-01-15 |
2021-07-22 |
Immatics Biotechnologies Gmbh |
Antigen binding proteins specifically binding prame
|
EP4096707A1
(de)
|
2020-01-30 |
2022-12-07 |
Umoja Biopharma, Inc. |
Bispezifischer transduktionsverstärker
|
WO2021175954A1
(en)
|
2020-03-04 |
2021-09-10 |
Imcheck Therapeutics Sas |
Antibodies having specificity for btnl8 and uses thereof
|
WO2021228956A1
(en)
|
2020-05-12 |
2021-11-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New method to treat cutaneous t-cell lymphomas and tfh derived lymphomas
|
WO2022002880A1
(en)
|
2020-06-29 |
2022-01-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti-protein s single-domain antibodies and polypeptides comprising thereof
|
AU2021320902A1
(en)
|
2020-08-07 |
2023-04-06 |
Spacecraft Seven, Llc |
Plakophilin-2 (PKP2) gene therapy using AAV vector
|
CA3190586A1
(en)
|
2020-09-04 |
2022-03-10 |
Merck Patent Gmbh |
Anti-ceacam5 antibodies and conjugates and uses thereof
|
MX2023005570A
(es)
|
2020-11-12 |
2023-05-29 |
Inst Nat Sante Rech Med |
Anticuerpos conjugados o fusionados al dominio de union del receptor de la proteina de la espicula de sars-cov-2 y usos de los mismos con fines de vacunacion.
|
MX2023007610A
(es)
|
2020-12-23 |
2023-07-12 |
Inst Nat Sante Rech Med |
Vacuna contra clamidia basada en el direccionamiento del antigeno momp vs4 a las celulas presentadoras de antigeno.
|
WO2022152698A1
(en)
|
2021-01-12 |
2022-07-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of npdk-d to evaluate cancer prognosis
|
WO2022159575A1
(en)
|
2021-01-20 |
2022-07-28 |
Bioentre Llc |
Ctla4-binding proteins and methods of treating cancer
|
WO2022164935A1
(en)
|
2021-01-27 |
2022-08-04 |
Umoja Biopharma, Inc. |
Lentivirus for generating cells expressing anti-cd19 chimeric antigen receptor
|
MX2023008986A
(es)
|
2021-01-29 |
2023-08-15 |
Inserm Institut National De La Sante Et De La Rech Medicale |
Polipeptidos antigenicos de chlamydia trachomatis y usos de los mismos con fines de vacuna.
|
WO2022184805A1
(en)
|
2021-03-03 |
2022-09-09 |
Immatics Biotechnologies Gmbh |
Antigen binding proteins specifically binding sars-cov-2 antigenic peptides in complex with a major histocompatibility complex protein
|
WO2022200469A1
(en)
|
2021-03-24 |
2022-09-29 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
A dominant negative protein of rad51 for treating cancer
|
EP4322937A1
(de)
|
2021-04-14 |
2024-02-21 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Neues verfahren zur verbesserung der antitumoraktivität von makrophagen
|
EP4322938A1
(de)
|
2021-04-14 |
2024-02-21 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Neues verfahren zur verbesserung der zytotoxizität von nk-zellen
|
IL308257A
(en)
|
2021-05-05 |
2024-01-01 |
Immatics Biotechnologies Gmbh |
Antigen binding proteins that uniquely bind PRAME
|
JP2024517377A
(ja)
|
2021-05-13 |
2024-04-22 |
ウニベルシダージ ド アルガルヴェ |
神経変性疾患に用いるための単離または人工ヌクレオチド
|
KR20240038028A
(ko)
|
2021-07-27 |
2024-03-22 |
이매틱스 바이오테크놀로지스 게엠베하 |
Ct45에 특이적으로 결합하는 항원 결합 단백질
|
WO2023012165A1
(en)
|
2021-08-02 |
2023-02-09 |
Universite De Montpellier |
Compositions and methods for treating cmt1a or cmt1e diseases with rnai molecules targeting pmp22
|
EP4130038A1
(de)
|
2021-08-03 |
2023-02-08 |
Institut national de recherche pour l'agriculture, l'alimentation et l'environnement |
Anti-il-2-antikörper, komplex damit und verwendungen davon
|
CA3232485A1
(en)
|
2021-11-15 |
2023-05-19 |
Technische Universitat Dresden |
Site-specific recombinases for efficient and specific genome editing
|
WO2023088968A1
(en)
|
2021-11-17 |
2023-05-25 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Universal sarbecovirus vaccines
|
WO2023099578A1
(en)
|
2021-12-01 |
2023-06-08 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Neutralizing anti-cd95l monoclonal antibodies
|
EP4209508A1
(de)
|
2022-01-11 |
2023-07-12 |
Centre national de la recherche scientifique |
Nanokörpern für das deneddylierende enzym nedp1
|
WO2023150563A1
(en)
|
2022-02-01 |
2023-08-10 |
Cornell University |
Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy associated with friedreich ataxia
|
WO2023156437A1
(en)
|
2022-02-16 |
2023-08-24 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti-robo4 human monoclonal antibodies and uses thereof for the treatment of cancer
|
WO2023161412A1
(en)
|
2022-02-25 |
2023-08-31 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies for preventing the cleavage of cd95l by metalloproteases
|
WO2023170239A1
(en)
|
2022-03-09 |
2023-09-14 |
Merck Patent Gmbh |
Methods and tools for conjugation to antibodies
|
WO2023170296A1
(en)
|
2022-03-11 |
2023-09-14 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Nucleic acid system to specifically reprogram b and t cells and uses thereof
|
WO2023217904A1
(en)
|
2022-05-10 |
2023-11-16 |
Institut National de la Santé et de la Recherche Médicale |
Syncitin-1 fusion proteins and uses thereof for cargo delivery into target cells
|
WO2023240287A1
(en)
|
2022-06-10 |
2023-12-14 |
Bioentre Llc |
Combinations of ctla4 binding proteins and methods of treating cancer
|
WO2024011237A1
(en)
|
2022-07-08 |
2024-01-11 |
Cornell University |
Methods and pharmaceutical compositions for the treatment and the prevention of alzheimers disease
|
WO2024017990A1
(en)
|
2022-07-21 |
2024-01-25 |
Institut National de la Santé et de la Recherche Médicale |
Methods and compositions for treating chronic pain disorders
|
WO2024052503A1
(en)
|
2022-09-08 |
2024-03-14 |
Institut National de la Santé et de la Recherche Médicale |
Antibodies having specificity to ltbp2 and uses thereof
|
WO2024056668A1
(en)
|
2022-09-12 |
2024-03-21 |
Institut National de la Santé et de la Recherche Médicale |
New anti-itgb8 antibodies and its uses thereof
|
WO2024061930A1
(en)
|
2022-09-22 |
2024-03-28 |
Institut National de la Santé et de la Recherche Médicale |
New method to treat and diagnose peripheral t-cell lymphoma (ptcl)
|
WO2024074571A1
(en)
|
2022-10-05 |
2024-04-11 |
Institut National de la Santé et de la Recherche Médicale |
Dc-targeting vaccine against nipah virus infection
|
WO2024079317A1
(en)
|
2022-10-14 |
2024-04-18 |
Institut National de la Santé et de la Recherche Médicale |
Methods and pharmaceutical composition for the treatment of alpha-synucleinopathies
|
PT118269A
(pt)
|
2022-10-20 |
2024-04-22 |
Univ De Aveiro |
Pkmyt1 for use in regenerative medicine
|